Retapamulin for Reducing MRSA Nasal Carriage

NCT01461668 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Methicillin-Resistant Staphylococcus Aureus

Interventions

DRUG: Retapamulin
DRUG: Placebo

Sponsor

University of California, Irvine

Collaborators

[object Object]